Skip to content

Electromagnetic Therapy for Cervicogenic Dysphagia

Efficacy of Electromagnetic Therapy in the Treatment of Cervicogenic Dysphagia: Randomized Single-blind Placebo-Control Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07765043
Enrollment
40
Registered
2026-08-14
Start date
2025-07-01
Completion date
2026-05-25
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Swallowing Disorder.Other Specified

Keywords

Deglutition, Electromagnetic Therapy, Exercise

Brief summary

Cervicogenic dysphagia (CD) is a swallowing disorder in patients with cervicogenic pathology. Pulsed electromagnetic therapy (PEMT) is a widely utilized therapeutic modality. Objective: To investigate the effects of PEMT on swallowing function (SF) and dysphagia handicapping effects in patients with CD. Methods: 40 volunteer participants (50-60 years old) with CD and cervical spondylosis were randomly and equally assigned to the study group (PEMT+swallowing resistance training program "SRTP") and control group (placebo PEMT+SRTP). Intervention: All participants received 3 sessions of SRTP (resisted chin tuck-in and resisted swallowing exercises) and 2 PEMT sessions (20 minutes of 20 Hz low frequency, 0.8 milli Tesla low intensity) per week for 8 weeks. Outcome Measures: The SF was evaluated using the swallow difficulty questionnaire "SDQ", and the dysphagia handicapping effects were evaluated using the dysphagia handicap index (DHI) pre-and post-study. Statistical analysis: Within-group comparisons were done using a paired t-test, and the between-group differences were examined using two-way ANOVA; a significant value was set at P\<0.05.

Detailed description

Swallowing represents an integrated sensorimotor process accomplished by coordinated muscular actions. Cervical spine structures, under normal conditions, play an important role in maintaining coordinated swallowing. The muscular and neural structures of the cervical spine are responsible for the coordinated movement of the larynx, pharynx, and hyoid bone during swallowing. Sensory information ascends from cervical structures to the brainstem, providing feedback to help synchronize the complex and harmonized contributions of the neck and throat muscles during swallowing. Disruption of this sensory feedback loop can result in coordination deficits and difficulty swallowing. Biomechanical alterations or degenerative changes in the cervical spine can affect its position and stability. These alterations may further impact the surrounding neural and muscular structures' functions, resulting in a variety of alarming symptoms and dysfunctional patterns that predispose to mechanical obstruction and difficulty swallowing. Cervicogenic dysphagia (CD) is an alarming disorder characterized by disturbed swallowing secondary to cervical structures dysfunction. Cervical spondylosis and associated pathological consequences can contribute to the development of CD. Cervical spine biomechanical alterations and malalignments, such as cervical kyphosis, a condition commonly encountered in cervical spondylosis, can predispose to pharyngeal dysfunction and difficult swallowing. The combined effects of neck muscular and articular dysfunctions represented in muscle weakness, poor cervical posture, and limited range of motion can disturb the cricopharyngeal sphincter action and the normal laryngeal function, ultimately predisposing to CD. Although cure of dysphagia is not always possible, conservative approaches can provide an effective path to alleviate patients' complaints. A comprehensive dysphagia management program is not only important to restore normal swallowing function, but also to eliminate the economic burden and the dysphagia-related health hazards. Low-frequency, low-intensity electromagnetic field therapy (EMT) is a safe, non-invasive therapeutic modality of clinical interest and effective applicability in the treatment of a variety of pathologies. Although the effectiveness of pulsed electromagnetic field therapy (PEMFT) as a safe and effective therapeutic modality was investigated in a variety of cervical pathologies, there is a lack of evidence supporting the effectiveness of PEMFT in the treatment of patients with cervicogenic dysphagia. Considering the reported safety and effectiveness of PEMFT therapy in the treatment of different pathologies, this study aimed to investigate the effects of PEMFT therapy on swallowing function and the dysphagia handicapping effects in patients with CD.

Interventions

BEHAVIORALThe pulsed electromagnetic field treatment program plus the swallowing resistance training program

The pulsed electromagnetic field treatment program plus the swallowing resistance training program

BEHAVIORALThe placebo pulsed electromagnetic field treatment program plus the swallowing resistance training program

The placebo pulsed electromagnetic field treatment program plus the swallowing resistance training program

Sponsors

Umm Al-Qura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

This study followed the pre-posttest, randomized, single-blind, parallel arm, placebo-controlled study design. All participants were blind to the PEMFT treatment (participants were not oriented towards the PEMFT, whether actual or placebo); assessors were blind to the groups' allocation and the received treatment, groups' allocation and study design.

Intervention model description

This interventional study aimed to investigate the effects of Low-frequency, low-intensity electromagnetic field therapy on swallowing function and the dysphagia handicapping effects in patients with Cervicogenic dysphagia (CD). Forty participants matched the inclusion criteria, provided informed consent agreeing to participate in the study and publication of its results, and were randomly allocated to either the study group (received PEMFT + swallowing resistance training program "SRTP"; n=20) or the control group (received placebo PEMFT + SRTP; n=20). The study primary outcomes (swallowing function and dysphagia handicapping effect) and the secondary outcomes (pain and forward head position) were evaluated at the beginning and at the end of the study.

Eligibility

Sex/Gender
ALL
Age
50 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Individuals diagnosed with cervicogenic dysphagia and cervical spondylosis * Age 50-60 years. * Individuals with a sedentary lifestyle (less than 30 minutes of aerobic activities per day). * Signed the written consent

Exclusion criteria

* Subjects diagnosed with rheumatological disease, cerebrovascular abnormalities * Subjects having a metal implant or previous cervical surgeries. * Subjects having received physical therapy programs for cervical spondylosis or dysphagia within the last 6 months. Subjects with recent infection, cognitive impairments or dementia, cardiovascular instability, head or neck traumatic injuries, neurological disorders affecting swallowing (e.g., parkinsonism, stroke). * Subjects who received medications interfering with normal swallowing function (e.g., antiepileptics, antipsychotics, and antidepressant drugs). * Subjects who refused to provide the signed informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Swallowing functionBaseline and post-8 weeksAssessment of the swallowing function using the Swallowing Disturbance Questionnaire, composed of 15 self-reported items.
The dysphagia handicapping effectsBaseline and post 8 weeks.The dysphagia handicapping effects assessment (using Dysphagia Handicap Index)

Secondary

MeasureTime frameDescription
Pain intensityBaseline and post 8 weeksAssessment of pain intensity using the 10 cm visual analog scale (VAS)
The forward head positionBaseline and post 8 weeksThe forward head position assessment (the craniovertebral angle)

Countries

Saudi Arabia

Contacts

PRINCIPAL_INVESTIGATORASHRAF AM ABDELAAL, Ph.D.

Umm Al-Qura University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026